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Abstract: The aim of the study was to create a specific pattern of protein expression changes in the plasma of 2-week-old calves treated
with excessive lactose doses. Identification of proteins, the expression of which changes during the short-term administration of lactose,
may help to exclude or confirm the causes of diarrhea observed in newborn calves. The present study utilized 2-D electrophoresis
combined with MALDI-TOF mass spectrometry and identified 6 blood plasma proteins, the expression of which changed under the
influence of lactose added to the milk replacer. The pattern of expression of blood plasma proteins, including decreased expression of
fibrinogen and apolipoprotein A-IV and increased expression of alpha-1B-glycoprotein, alpha-1-antiproteinase, and apolipoprotein E
in 2-week-old calves fed with lactose-rich milk replacer, can be used to determine the causes of diarrhea in calves.
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1. Introduction
Significant mortality is observed in calves during the first
3 weeks of their life, and the predominant cause of death
is diarrhea. Among the causes listed as responsible for
the occurrence of diarrhea are noninfectious factors (e.g.,
oversupply of milk or milk replacer) and infectious factors
(e.g., rotavirus, coronavirus, enterotoxigenic E. coli).
The occurrence of diarrhea in calves is triggered by the
accumulation of undigested lactose in the gastrointestinal
tract due to its oversupply with milk replacer (1).
Biochemical analysis of plasma and urine is commonly
used during veterinary diagnostics. The overall analysis
of a particular body fluid proteome enables a deeper
understanding of metabolic processes and the mechanisms
regulating the expression of proteins in health and disease.
Determination of qualitative and quantitative changes
in the peptide-protein composition of body fluids,
which is constantly changing in response to systemic or
environmental factors (including experimental variables),
allows for the determination of marker proteins,
characteristic for a specific physiological or pathological
condition (2).
The aim of the study was to create a specific pattern
of protein expression changes in the plasma of 2-week-old
calves treated with excessive lactose doses. Identification
* Correspondence: alicja.dratwa-chalupnik@zut.edu.pl

of proteins, the expression of which changes during the
short-term administration of lactose, may help to exclude
or confirm the causes of diarrhea observed in newborn
calves.
2. Materials and methods
The experiment was carried out on 6 Polish HolsteinFriesian var. Black-and-White male calves from the 13th
to the 16th day of life. The use and handling of animals for
this experiment was approved by the Local Commission
of Ethics for the Care and Use of Laboratory Animals
(No. 3/2010 of 14.01.2010). During the first 3 days of life,
calves were fed colostrum, and then from the 4th day
milk replacer in an amount of 10% of body weight per
day. Animals were fed milk replacer (Mlekovit Imupro,
Polmass) containing 23% crude protein, 16% crude fat,
0.1% crude fiber, 45% lactose, 7.5% crude ash, 1.7% lysine,
0.42% methionine, 0.9% calcium, and 0.7% phosphorus.
Calves were fed twice daily. On the 13th day (during the
evening feeding) and on the 14th day (during the morning
feeding) monohydrate lactose (Pharma Cosmetic) in the
amount of 1 g/kg of body weight was added to the milk
replacer.
Blood samples were collected once, always before the
evening feeding. Blood was drawn from the jugular vein
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into K2EDTA precoated tubes. The blood samples were
centrifuged (15 min, 4 °C, 3000 × g) and the harvested
plasma was stored at –80 °C until further processing.
2.1. Two-dimensional electrophoresis (2-DE)
Before 2-DE analysis, plasma samples were processed by
protein equalizer technology with a ProteoMiner LargeCapacity Protein Enrichment Kit (Bio-Rad).
Processed plasma samples were dissolved in lysis
buffer containing 7 M urea, 2 M thiourea, 4% w/v CHAPS,
1% w/v DTT, 0.2% w/v 3-10 ampholytes, and 2 mM TBP.
Plasma protein samples (650 µg) were applied to 4–7 NL
(nonlinear) ReadyStrip IPG Strips (24 cm, Bio-Rad). The
isoelectrofocusing (IEF) was run at a total of 90,000 Vh
using a Protean IEF Cell (Bio-Rad). After IEF, the IPG
strips were reduced with DTT in equilibration buffer
(6 M urea, 0.5 M Tris/HCl, pH 6.8, 2% w/v SDS, 30% w/v
glycerol, and 1% w/v DTT) for 15 min and then alkylated
with iodoacetamide (2.5% w/v) for 20 min at ambient
temperature. The second dimension was performed on
12% SDS polyacrylamide gels (20 × 25 cm) at 40 V for 2.5
h and then at 100 V for 17 h at 10 °C using a Protean Plus
Dodeca Cell electrophoretic chamber (Bio-Rad). After
2-DE separation, the gels were stained with CBB G-250
according to the modified Kang method (3).
2.2. Image analysis
The gels were scanned using a GS-800 Calibrated
Densitometer (Bio-Rad). Analysis of 2-D images was
performed using PDQuest Analysis software version 8.0.1
Advanced (Bio-Rad). To measure the variability before and
after administration of lactose, the coefficient of variation
was calculated. Qualitative and quantitative comparisons
before and after administration of lactose were performed
to show the differences in the pattern of protein spots
and to examine changes in the protein expression level.
Experiment normalization was performed using a local
regression model (LOESS). Molecular mass (kDa) was
computed for each identified protein spot based on the
molecular weight standard.
2.3. Mass spectrometry and functional protein clustering
The protein spots showing statistically significant
differences were manually excised from the gels and
decolorized by washing in buffer containing 25 mM
NH4HCO3 in 5% v/v acetonitrile (ACN), followed by two
washes with a solution of 25 mM NH4HCO3 in 50% v/v
ACN. The gel pieces were dehydrated (100% ACN), vacuum
dried, and incubated overnight with trypsin (20 µL/spot of
12.5 µg trypsin/mL in 25 mM NH4HCO3; Promega) at 37
°C. The resulting peptides were extracted with 100% ACN,
combined with an equal volume of matrix solution (5 mg/
mL CHCA, 0.1% v/v TFA, 50% v/v ACN), and loaded
onto a MALDI-MSP AnchorChip 600/96 plate (Bruker
Daltonics). Peptide Mass Standard II was used (mass
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range 700–3200 Da, Bruker Daltonics) for calibration of
the mass scale. Mass spectra were acquired in positiveion reflector mode using a Microflex MALDI-TOF
(matrix-assisted laser desorption/ionization time of flight)
mass spectrometer (Bruker Daltonics). Peptide mass
fingerprinting (PMF) data were compared to mammalian
databases (SWISS-PROT, http://us.expasy.org/uniprot/
and NCBI, http://www.ncbi.nlm.nih.gov/) with the aid of
the MASCOT search engine (http://www.matrixscience.
com/). Search criteria included trypsin as an enzyme,
carbamidomethylation of cysteine as a fixed modification,
methionine oxidation as a variable modification, mass
tolerance to 150 ppm, and a maximum of one missed
cleavage site. The results were further validated by the
MASCOT score (only statistically significant hits were
applied) and sequence coverage.
3. Results
The experiments involved electrophoretic separation of
blood plasma proteins of calves (Figure 1). Twelve 2-D gels
were obtained, reflecting the protein profiles of the blood
plasma of calves prior to the first dose of lactose and 12
h after the second dose of lactose was added to the milk
replacer formulation.
Archived gels were analyzed using bioinformatics
software PDQuest 8.0 Advanced (Bio-Rad). In total, 430
spots were analyzed qualitatively and quantitatively, of
which 136 were present in all analyzed gels, showing the
protein profiles of the blood plasma of calves both prior
to administration of the milk replacer containing lactose
and after the supply of the formulation. Of these, 6 showed
statistically significant differences in expression. Three
spots showed increased expression, while the expression of
the remaining 3 was decreased. The spots, which showed
differences in the expression, represented 6 proteins
(Figure 2).
An example of a gel, which demonstrates the blood
plasma protein spots differing in expression, is presented
in Figure 1. The Table describes in detail the identified
protein spots. Figure 1 depicts the pI range (corresponding
to the pH of the 4–7 IPG strips) and molecular weight in
the range of 20 to 250 kDa. The Table presents detailed
information on protein spots differing in relative expression
after analysis using PDQuest software; characteristics of
blood plasma proteins are also given (name, accession
number, estimated molecular weight, isoelectric point –
pI, molecular weight – MW), based on the SWISS-PROT
and NCBI databases. The results also include a point
value, reflecting the reliability of identification (so-called
SCORE), the percentage of coverage of identified amino
acid sequence fragments for the analyzed proteins, and
the number of fragments matched with the amino acid
sequence of the protein.
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Figure 1. The 2-DE map of differentially expressed calves plasma proteins. Presented 2-D gel was stained with Coomassie brilliant blue
G-250; 650 µg of protein was applied to the IPG strip (24 cm, pH 4–7) for the first dimension and the second dimension was performed
on 12% SDS-PAGE gels. Spot numbers correspond to those in the Table and Figure 2.
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Figure 2. Differentially expressed blood plasma proteins. The short names of the identified proteins, spot numbers, graph of differences
in abundance, and changes in spot intensities are presented in the expanded view of the gel. Spot numbers of the identified proteins
correspond to those presented on the 2-DE map of calves’ plasma proteins (Figure 1) and described in the Table.

The concentration of glucose in the blood plasma
of 2-week-old calves before lactose administration was
4.27 mmol L–1 and its level increased to 4.42 mmol L–1 12 h
after the second dose of lactose (Figure 3).

Soft stool with a delicate sour odor and small green mucus
streaks was observed in all calves after administration of milk
replacer with additional quantity of lactose. This may indicate
a change in the rate of passage of gastric contents.
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Fibrinogen gamma-B chain isoform X1

Fibrinogen alpha chain isoform X1

Alpha-1B-glycoprotein precursor

Alpha-1-antiproteinase

Apolipoprotein A-IV

Apolipoprotein E

1.

2.

3.

4.

5.

6.

CAA43479

ELR56104

P34955

NP_001039708

XP_005217494

XP_005217490

Accession no.

38.2

43.6

74.5

82.8

6802.0

174.2

5.44/35.96

5.31/43.01

6.05/46.42

5.29/54.09

5.69/95.42

5.56/49.76

Theoretical
pI/Mr
[kDa]

2537.8

8075.5

535.2

448.5

458.8

4572.4

159.71

1810.27

255.23

64.53

139.96

2557.90

SD

3444.6

3695.1

1010.1

673.5

147.7

979.8

Mean
relative
abundance
after
lactose
addition

476.10

578.09

189.86

31.90

157.44

562.45

SD

1.36

–2.18

1.89

1.50

–3.11

–4.67

Fold
change

P ≤ 0.05

P ≤ 0.05

P ≤ 0.05

P ≤ 0.01

P ≤ 0.05

P ≤ 0.05

Significance
of
differences

141

183

73

113

102

198

Mascot
score

46

52

25

31

22

54

Sequence
coverage
[%]

MALDI-TOF MS

Spot numbers of the identified proteins correspond to those presented on the 2-DE map of calves’ plasma proteins (Figure 1) and on the graph of differences in abundance and changes in spot intensities (Figure 2).

Protein name

Calculated
Mr
[kDa]

Mean
relative
abundance
before
lactose
addition

The list of the differentially expressed calves blood plasma proteins and characterization of the parameter identification using MALDI-TOF mass spectrometer.

Spot
no.

Table.

17

21

14

13

14

19

Mass
values
matched
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Figure 3. Mean blood plasma glucose concentration in calves
before and after supply of lactose.

4. Discussion
The present study utilized 2-D electrophoresis combined
with MALDI-TOF mass spectrometry and identified 6
blood plasma proteins, the expression of which changed
under the influence of lactose added to the diet.
We have shown a decrease in the expression of plasma
fibrinogen gamma-B chain isoform X1 and fibrinogen
alpha chain isoform X1 after administration of lactose
with milk replacer. Fibrinogen (Fb) is a glycoprotein
produced by the parenchymal hepatic cells and released
into the bloodstream as a dimer. Each fibrin monomer
is composed of three polypeptide chains, α, β, and γ,
connected by disulfide bonds (4,5).
Fibrinogen, in addition to the hemostatic function,
acts as one of the acute phase proteins. Hepatic synthesis
of Fb and then release into the bloodstream increases
significantly under the influence of proinflammatory
agents (6).
Studies of Ge et al. (7) and Guo et al. (8) indicated
that fibrinogen and especially its D domain increased
vascular endothelial permeability. Guo et al. (8) suggested
that the C-terminus of fibrinogen γ was responsible for
an increase in microvascular endothelial permeability. In
turn, Ge et al. (7) showed that the D fragment increased
endothelial permeability of bovine pulmonary artery
independently of the carboxy-terminal sequence of the
gamma-chain. According to Guo et al. (8), fibrinogeninduced permeability might explain macromolecule
transport across the microvascular endothelium during
inflammation.
The concentration of fibrinogen in the blood plasma
of calves is decreasing from 13 to 20 days of age (9). In the
available literature, there are no data related to the effect

of lactose supplementation to the diet on blood fibrinogen
concentration. Gökçe et al. (10) and Sobiech et al. (11)
observed a higher concentration of this protein in calves
with diarrhea in comparison to calves of the control group.
In spite of slight diarrhea, as a result of lactose supply, a
decrease was observed in the expression of Fb in the blood
plasma of the subject calves. Fibrinogen can be considered
as an indicator protein in determining the cause of diarrhea
in calves. Decreased blood Fb concentration in calves with
diarrhea may indicate that it was caused by a noninfectious
agent (in this case, oversupply of lactose).
Alpha-1B-glycoprotein (A1BG) is a plasma protein,
the expression of which in blood plasma increased in
response to the addition of lactose to milk replacer. The
function of this protein is still unknown. It belongs to
the immunoglobulin family and is a protein released
into the blood plasma. The increase in the expression of
A1BG in serum was observed in cattle and sheep during
respiratory tract inflammation (12,13). It seems that
diarrhea observed in calves in response to the oversupply
of lactose may result in increased concentrations of A1BG
in their blood plasma.
Alpha-1-antiproteinase is a glycoprotein synthesized
primarily in the liver and secreted into the bloodstream.
To a lesser extent, it is synthesized by macrophages,
pulmonary alveolar cells, and intestinal and corneal
epithelium. Alpha-1-antiproteinase belongs to the acutephase proteins. It is released during inflammatory
response and inactivates many proteolytic enzymes such
as neutrophil elastases (14,15).
The concentration of alpha-1-antiproteinase in
the blood plasma increases rapidly in response to
inflammation or infection (14,15). It can be assumed that
the increase in expression of this protein in the blood
plasma of calves was caused by the lactose maldigestion
because of lactose supply exceeding the enzymes’ capacity
to break down lactose to glucose and galactose. Undigested
lactose attracts water and electrolytes to the digestive tract,
resulting in loose stool.
Further proteins, the expressions of which in blood
plasma of calves changed after the addition of lactose to
milk replacer, were involved in the metabolism of fat:
apolipoprotein A-IV and apolipoprotein E.
A study by Minehira et al. (16) showed that carbohydrate
overfeeding markedly increased net de novo lipogenesis at
the expense of glycogen synthesis and increased mRNA
levels for the key lipogenic enzymes. Lepczyński et al.
(17) observed lower blood plasma concentrations of total
cholesterol, HDL-cholesterol, and LDL-cholesterol and
downregulation of apo A-IV in preruminant calves fed
milk replacer in comparison to calves fed whole milk.
Moreover, the authors showed that the milk replacer had
a much higher carbohydrate content than the milk (17).
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Apolipoprotein A-IV is a glycoprotein synthesized
primarily in the enterocytes of the small intestine
during fat absorption. In the blood, apo A-IV occurs
primarily in the free form; the remaining amount is
present in chylomicrons and high-density lipoproteins.
This protein is involved in absorption, transport, and
metabolism of lipids, and it may also act as a postprandial
satiety signal and an antioxidant (18,19). In piglets with
induced experimental inflammation, decreased hepatic
apo A-IV mRNA expression was observed (20). In
addition, a decrease of apo-IV free form (lipoprotein-free
apolipoprotein) was also demonstrated as well as a form
associated with high-density lipoproteins in blood plasma.
Sato et al. (21) observed a decrease in the concentration
of apo-AIV mRNA in the intestine of fasted rat pups that
in the 15th hour of fasting reached a value equal to 20% of
the prefasting level. Refeeding of lactose or milk replacer
increased the concentration of apo A-IV in the intestine,
but it had no effect on the level of apo A-IV in the serum.
Only the administration of Intralipid alone to fasted pups
contributed to increased levels of apo A-IV in the serum 3
h after refeeding. Satoh et al. (22) also observed an increase
in the concentration of apo A-IV in serum in 14-day-old
suckling rat pups fasted overnight after administration
of Intralipid along with lactose, glucose, fructose, and
sucrose.
Apolipoprotein E (apo E) is a class of apolipoproteins
found in the chylomicron and intermediate-density
lipoprotein. It binds to a specific liver and peripheral cell
receptor and is essential for the normal catabolism of
triglyceride-rich lipoprotein constituents. Apo E present
in the blood plasma is primarily derived from the liver.
It has been shown that this protein is also synthesized in
the spleen, brain, lungs, and kidneys. In addition to the
regulation of lipid metabolism, apo E is involved in the
modulation of the inflammatory response and oxidative
stress (23).

The study of Wang et al. (24) showed in mice that
exogenous apo A-IV injection decreases blood glucose
levels and stimulates a transient increase in insulin
secretion. Gao et al. (25) observed in mice with apo E
deficiency reduced blood glucose and better insulin
sensitivity. Considering the above publications, it can be
assumed that the increased amount of glucose supplied
with food could be the cause of the observed decreased
expression of apo A-IV and increased expression of apo E
in the blood plasma of tested calves.
The acute-phase response in the body occurs due to
various stimuli, including metabolic disorders arising
from dietary errors. Changes in the concentrations of
the acute-phase proteins are dependent on the stimulus
that induced them. In the present experiment, triggering
the acute-phase response and proteins involved in this
process (fibrinogen, alpha-1B-glycoprotein, alpha-1antiproteinase, apo A-IV, apo E) was a reaction to the
increased quantity of disaccharide-lactose administered to
calves with milk replacer formulation.
The observed changes in protein expression of
blood plasma in calves were caused by the direct
effect of an oversupply of sugar (apo A-IV, apo E) or
diarrhea (fibrinogen, alpha-1B-glycoprotein, alpha-1antiproteinase).
The pattern of expression of blood plasma (decreased
expression: fibrinogen, Apo IV; increased expression:
alpha-1B-glycoprotein, alpha-1-antiproteinase, and apo E)
in 2-week-old calves treated with an oversupply of lactose
can be used to determine the causes of diarrhea in calves.
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